We examined the psychopharmacological services provided within 3 months of nursing home (NH) admission to a whole population of newly admitted Florida NH residents 65 years and older ( N = 947) for a 1-year period via secondary analyses of selected variables from Medicaid and the Online Survey and Certifi cation and Reporting System. Within 3 months of admission, 12% received nonpsychopharmacological mental health care. However, 71% of new residents received at least one psychoactive medication, and more than 15% were taking four or more psychoactive medications. Most of those being treated with psychoactive medication had not received psychopharmacological treatment 6 months prior to admission (64%) and had not received a psychiatric diagnosis 6 months preceding admission (71%). Blacks were less likely to receive medications than non-Hispanic Whites. Results expand on past research by identifying an increase in the amount of psychoactive medications prescribed to NH residents, a lack of prior psychiatric treatment and diagnoses for those currently receiving psychoactive medications, only limited provision of nonpsychopharmacological mental health care, and racial or ethnic differences in the use of medications by NHs.
T HE 1987 Omnibus Budget Reconciliation Act (OBRA 87; Turnham, 2001 ) mandated that nursing home (NH) residents be screened for mental health problems prior to admission, furnished guidelines to reduce inappropriate medication usage and physical restraints, and promoted nonpharmacological approaches to mental health care via more favorable reimbursement under Medicare. Unfortunately, since OBRA ' s passage, studies suggest only modest changes in the usage of antipsychotic drugs or implementation of behavior management programs ( Hawes et al., 1997 ) . One study reported a recent upsurge in the usage of antipsychotic medications to levels not seen in a decade, with less than half of the treated residents receiving this medication in compliance with NH guidelines ( Briesacher et al., 2005 ) . A possible reason for inappropriate medication prescription may be that half of all NHs do not have access to a psychiatrist and three-quarters do not have access to behavioral consultants ( Reichman et al., 1998 ) . Indeed, French, Campbell, Spehar, and Accomando (2007) used the Minimum Data Set to examine long-term NH residents of all Veterans Administration NHs and found little association between use of psychotropic medications and mental health diagnoses.
Recent studies in NHs document the deleterious effects of overmedication, suggesting a link between total psychoactive drug " load " and risk of hospitalization ( Cooper, Freeman, Cook, & Burfi eld, 2007 ) , use of psychoactive medications and increased preventable adverse drug events ( Gurwitz et al., 2000 ) , effect of some antidepressants on fall risk ( Draganich, Zacny, Klafta, & Karrison, 2001 ) , and a host of problems associated with chronic benzodiazepine usage ( Svarstad & Mount, 2001 ) . Clearly, the intent of OBRA has not been realized over the 22 years since its passage. In a joint position statement on psychotherapeutic medication in NHs ( American Geriatrics Society, 1997 ), the American Geriatrics Society and the American Association of Geriatric Psychiatry placed emphasis on distinguishing between the appropriate and inappropriate prescription of psychoactive medications based on an understanding of the complexities involved in diagnosing psychological conditions in NH residents, who are typically White widowed women in their mid-80s with multiple comorbidities and signifi cant limitations in their activities of daily living and instrumental activities of daily living ( Sahyoun, Pratt, Lentzner, Dey, & Robinson, 2001 ).
More research on structural characteristics of NHs may lead to the identifi cation of process variables that would enable regulators, administrators, and geriatric mental health practitioners to remediate those NHs with a high number of citations ( Castle, 2001 ) . For example, Castle and Shea (1997) found that an institutional waiting list, chain membership, and larger bed size are associated with more mental health services provision. Castle found that more defi ciency citations in mental health were related to larger facilities and chain membership and that fewer defi ciencies were associated with more mental health specialists per bed and higher average Medicare and private pay occupancies. We posed two questions addressing the current state of mental health services in NHs: What sociodemographic and institutional factors are associated with the receipt of psychopharmacological care within 3 months of admission? What is the relationship between receipt of current psychopharmacological care within 3 months of admission and past psychopharmacological treatment and psychiatric diagnosis within at least 6 months prior to admission?
M ethods
Inclusion criteria were older NH residents who had Medicaid eligibility at least 1 year prior to NH admission and who were enrolled in Florida NH facilities in the calendar year (CY) 2003. Because the focus of this study was psychopharmacological service delivery for new older adult long-term NH residents, those residents who stayed less than 3 months in the facility were excluded, as were residents younger than 65 years, and those who had previous NH claims within at least 12 months prior to the current admission of CY 2003. Of the 80,448 Medicaid residents admitted to NHs during the study year, the fi nal population consisted of 947 residents after inclusion and exclusion criteria were applied.
For the analyses, two data sets were combined. To address the sociodemographic factors associated with receipt of psychopharmacological care, we accessed Medicaid data for July 1, 2002 1, , to December 31, 2003 , and Online Survey and Certifi cation and Reporting System (OSCAR) data for CY 2003. To address the institutional factors associated with psychopharmacological care, CY 2003 OSCAR data were linked with CY 2003 Medicaid data. The resulting data set provided information on profi t status (nonprofi t, profi t, government), number of beds (<120, 120, >120; 120 beds is the standard-sized NH in Florida, with many NHs built to this exact bed size), location of NHs (urban or rural), and percentage of Medicaid residents. For the question concerning the amount of psychopharmacological care received by NH residents, Medicaid fee-for-service claims and procedure codes were accessed for all residents of Florida NHs from July 1, 2002 , to December 31, 2003 Logistic regression analyses determined the extent of association between sociodemographic and institutional characteristics and current receipt of psychopharmacological care. Subanalyses targeted two overlapping subgroups of NH residents: those who had received previous psychopharmacological services and those who had a past mental health diagnosis. For these two variables, some residents had only 6 months of data and the rest had a full year of data.
R esults
Over 74% of the sample were women, 73.2% were nonHispanic Whites, almost 12% were Black, and another 10% were Hispanic. Mean age for these new residents was 83 years ( SD = 7.97), and 80.6% remained in the admitting NH for more than 6 months. Thirty-six percent of the new residents were placed in facilities with a relatively large number of beds (>120 beds), 43% in facilities with a medium number of beds (120 beds), and 21% in facilities with a low number of beds (<120 beds). Almost 79% of the residents had entered " for-profi t " NHs, 20% nonprofi t, and only 1% had entered a " government " type of NH.
Among the 947 new Medicaid NH residents, over 71% were receiving psychoactive medications within 3 months of admission, including 71% of those with no prior psychiatric diagnosis and 73% of those with such a diagnosis. More than 15% of all new admissions were taking four or more medications within 3 months of admission. Twelve percent received nonpsychopharmacological care. Table 1 provides descriptive data and logistic regression analyses of the factors associated with the receipt of psychopharmacological care within the fi rst 3 months following admission. Approximately 13% of all new admissions entered with a psychiatric diagnosis recorded within 1 year prior to admission. Prior psychiatric diagnosis did not have a signifi cant infl uence on current receipt of psychoactive medications (OR = 1.12, CI = 0.73 -1.71), that is, the majority were administered medications regardless of their diagnostic history. However, unlike the effect of prior diagnosis, medication history within 1 year prior to admission signifi cantly increased the likelihood of receiving medications within 3 months of admission (OR = 3.14, CI = 2.22 -4.44). More than 34% of the residents had received prior psychiatric medications. Although 64% of those without a recent history of medications began receiving them within 3 months of admission, 85% of those with a recent history of medication usage were also taking medications within 3 months of admission.
One sociodemographic characteristic, but no institutional characteristics, was associated with receipt of psychopharmacological medication. Black residents were signifi cantly less likely than non-Hispanic Whites to receive psychopharmacological care (OR = .377, CI = 251 -567), whereas Hispanics were not signifi cantly different. However, in separate analyses not reported in Table 1 , it was found that for data related to a full year of NH residence, Blacks remained signifi cantly lower, but Hispanics were signifi cantly more likely than non-Hispanic Whites to receive psychiatric medications (OR = 2.39, CI = 1.02 -5.61).
D iscussion
This brief report examined the extent of psychiatric medication usage for Medicaid recipients within 3 months of NH admission and determined that more than 70% of NH residents are prescribed at least one psychoactive medication despite the majority receiving neither a recent prior psychiatric diagnosis nor prior psychopharmacological treatment. Our fi ndings from this large secondary data analysis are consistent with recent NH research documenting an overall increase in prescription of psychotropic medications over the last few years ( Briesacher et al., 2005 ) . The results confi rm continued limited nonpharmacological care relative to psychopharmacological treatment. Nonpharmacological approaches to reduce behavior problems are often recommended as fi rst line options but implementation of OBRA ' s recommendations in this area remains sporadic at best.
A number of possible explanations exist for the discrepancy between the lower prevalence of psychopharmacological treatment prior to NH admission and the much greater extent after admission. It is possible that new NH residents who received psychopharmacological treatment within 3 months of admission had a previously undiagnosed psychiatric condition because of poor family understanding of mental health problems and/or underdiagnosis of psychiatric problems in primary care settings ( Anfi nson & Bona, 2001 ) yielding reduced diagnostic acumen. A second possibility is that NH placement precipitated a psychiatric crisis necessitating psychopharmacological care. NH placement has been associated with psychiatric morbidity, but the extent of medication usage documented in this study suggests that there may be other reasons for such a high prevalence of psychopharmacological treatment. A third possibility is that the NH residents are being treated with psychoactive medications for neurological conditions or are being treated with off-label uses of the psychoactive medications. Lending credence to this latter possibility, post hoc analyses of the very limited accessible data on current diagnosis indicates that " other mental health " and " other dementia " diagnoses comprise the top percentages of psychiatric diagnoses.
A fourth explanation may be that new NH residents are not undergoing the rigorous evaluation that psychiatric diagnosis entails both prior to and after NH admission and are being prescribed psychoactive medications as a means of behavioral control ( French et al., 2007 ) . The problem of appropriate versus inappropriate usage of psychotropic medications has been long debated, and the consensus is that documentation for the prescription of psychotropic medications is less than optimal. Finally, it could be that NH residents are being placed on psychoactive medications for appropriate clinical reasons that are newly identifi ed due to the much greater staff surveillance made possible by residence in a facility.
Whatever the source of the increase in medications, the current medically oriented diagnostic system may not adequately represent the complex psychological symptom presentation of this increasingly frail cognitively impaired NH population with social needs as well as medical illnesses. The rise in the number of assisted living facilities (typically admitting those with less functional disability) obliges NHs to care for the most sick. Moreover, the issues with hiring and maintaining an appropriately trained geriatric health care workforce to assess and manage mental health problems in the long-term care system are formidable. Although the principal focus of this study was on the prevalence of psychiatric medication use, the demographic correlates of those new NH residents taking psychiatric medications were also of interest. Among those newly admitted to NHs, for example, older Blacks were less likely to receive psychiatric medications than non-Hispanic Whites. Our results clearly suggest that further attention should be paid to racial/ethnic differences in the use of medications by NHs.
This study has a number of limitations. Most NH residents are dually eligible for both Medicare and Medicaid reimbursement, and it is possible that some diagnostic and service claims data were completed only for Medicare billing without crosswalk linkage of claims information to Medicaid and therefore were not captured by our database. Another limitation is that because medication billing is a " bundled " service, Florida Medicaid does not reimburse psychiatric services rendered in the NH setting, and thus reliable diagnostic information via claims data was not available to determine justifi cation for current treatment. Furthermore, without access to incident report data and resident charts, we were unable to determine the nature of the events that generated the prescription of medications. Finally, this is a study only of economically disadvantaged Florida residents who were in the Medicaid system for up to 2 years, and in NH for at least 1 year; results may not necessarily generalize to non-Florida residents or those who do not meet the earlier criteria. It should be noted, however, that although Florida is the state with the oldest mean population, its occupancy rates, proportion of for-profi t NHs, average number of beds per facility, percentage of residents with dementia, and percentage of residents receiving psychoactive medications are close to the national averages ( Harrington, Carrillo, & Blank, 2007 ) .
In conclusion, the fi nding that a number of newly admitted NH residents receive one or multiple psychoactive medications despite having neither prior psychopharmacological treatment nor prior psychiatric diagnosis is cause for concern, and the overall thrust of these fi ndings clearly highlights the need for detailed reviews of treatment planning in NHs. OBRA and the Pre-admission Screening and Annual Resident Review do not appear to be suffi cient gatekeepers to guarantee optimal quality mental health care for NH residents with mental illness. Accountable systems need to be in place to assure that new residents are given a proper evaluation by appropriately trained geriatric mental health professionals. More research is needed to determine the specifi c resident, staff, regulatory, licensure, and institutional factors associated with the proper receipt of both pharmacological and nonpharmacological care across diverse groups of long-term care residents.
